[go: up one dir, main page]

DE602006020137D1 - Flüssige Zusammensetzung für die Behandlung und/oder Verhinderung von verschiedenen metabolischen Knochenkrankheiten, Verwendung davon und Vorbereitungsprozess. - Google Patents

Flüssige Zusammensetzung für die Behandlung und/oder Verhinderung von verschiedenen metabolischen Knochenkrankheiten, Verwendung davon und Vorbereitungsprozess.

Info

Publication number
DE602006020137D1
DE602006020137D1 DE602006020137T DE602006020137T DE602006020137D1 DE 602006020137 D1 DE602006020137 D1 DE 602006020137D1 DE 602006020137 T DE602006020137 T DE 602006020137T DE 602006020137 T DE602006020137 T DE 602006020137T DE 602006020137 D1 DE602006020137 D1 DE 602006020137D1
Authority
DE
Germany
Prior art keywords
prevention
treatment
preparation process
liquid composition
bone diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006020137T
Other languages
English (en)
Inventor
Liliana Elizabeth Diaz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gador SA
Original Assignee
Gador SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gador SA filed Critical Gador SA
Publication of DE602006020137D1 publication Critical patent/DE602006020137D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE602006020137T 2006-09-04 2006-09-04 Flüssige Zusammensetzung für die Behandlung und/oder Verhinderung von verschiedenen metabolischen Knochenkrankheiten, Verwendung davon und Vorbereitungsprozess. Active DE602006020137D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06018423A EP1894557B1 (de) 2006-09-04 2006-09-04 Flüssige Zusammensetzung für die Behandlung und/oder Verhinderung von verschiedenen metabolischen Knochenkrankheiten, Verwendung davon und Vorbereitungsprozess.

Publications (1)

Publication Number Publication Date
DE602006020137D1 true DE602006020137D1 (de) 2011-03-31

Family

ID=37440291

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006020137T Active DE602006020137D1 (de) 2006-09-04 2006-09-04 Flüssige Zusammensetzung für die Behandlung und/oder Verhinderung von verschiedenen metabolischen Knochenkrankheiten, Verwendung davon und Vorbereitungsprozess.

Country Status (14)

Country Link
EP (1) EP1894557B1 (de)
AR (1) AR062596A1 (de)
AT (1) ATE498391T1 (de)
AU (1) AU2007294261B2 (de)
CL (1) CL2007002514A1 (de)
CY (1) CY1111202T1 (de)
DE (1) DE602006020137D1 (de)
DK (1) DK1894557T3 (de)
ES (1) ES2361333T3 (de)
MY (1) MY148248A (de)
PL (1) PL1894557T3 (de)
PT (1) PT1894557E (de)
SI (1) SI1894557T1 (de)
WO (1) WO2008028547A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103191414B (zh) * 2013-03-29 2014-10-22 武汉中博绿亚生物科技有限公司 一种宠物快速吸收的液体钙及其制备方法
CN116616449A (zh) * 2023-06-05 2023-08-22 浙江索契壹营养科技有限公司 一种酸性抗菌体系稳定承载高钙和维生素d的饮液及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5462932A (en) * 1994-05-17 1995-10-31 Merck & Co., Inc. Oral liquid alendronate formulations
US7560490B2 (en) * 2001-01-23 2009-07-14 Gador S.A. Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereof

Also Published As

Publication number Publication date
ATE498391T1 (de) 2011-03-15
WO2008028547A1 (en) 2008-03-13
MY148248A (en) 2013-03-29
ES2361333T3 (es) 2011-06-16
AU2007294261B2 (en) 2012-09-06
DK1894557T3 (da) 2011-05-30
AU2007294261A1 (en) 2008-03-13
CY1111202T1 (el) 2015-06-11
PT1894557E (pt) 2011-03-02
PL1894557T3 (pl) 2011-07-29
AR062596A1 (es) 2008-11-19
EP1894557B1 (de) 2011-02-16
SI1894557T1 (sl) 2011-04-29
EP1894557A1 (de) 2008-03-05
CL2007002514A1 (es) 2008-01-11

Similar Documents

Publication Publication Date Title
EP2331192A4 (de) Mikroelektrodenstimulation zur behandlung von epilepsie und anderen neurologischen erkrankungen
DE602006019838D1 (de) Piperazinsubstituierte benzothiophene zur behandlung von geisteskrankheiten
EP1759710A4 (de) Mittel zur behandlung oder prävention von arthritis
EP2985281A3 (de) Isoindolin-verbindungen zur behandlung von krebs
ATE512663T1 (de) Kombination zur behandlung von erkrankungen mit zellproliferation
DE602006018583D1 (de) Verfahren und zusammensetzung zur behandlung von peripheren gefässkrankheiten
EP2282737A4 (de) Zusammensetzungen und verfahren zur behandlung von parodontalerkrankung mit clonidin, sulindac und/oder fluocinolon
EP1916964A4 (de) Implantate und verfahren zur behebung, ersetzung und behandlung von gelenkkrankheiten
EP1991274A4 (de) Verfahren zur behandlung, prophylaxe und diagnose von knochenerkrankungen
ATE526991T1 (de) Zusammensetzungen und ihre verwendungen für die gentherapeutische behandlung von knochenerkrankungen
EP2010184A4 (de) Implantate zur behandlung von dopamin-assoziierten zuständen
ATE512948T1 (de) Biphenyl-sulfonyl- und phenyl-heteroaryl-sulfonyl-modulatoren des histamin-h3-rezeptors zur behandlung von damit verbundenen erkrankungen
EP2135858A4 (de) Zusammensetzung zur behandlung von infektionserkrankungen
ATE429218T1 (de) Pinolensäure zur behandlung von übergewicht
ATE476414T1 (de) Biphenyloxyessigsäurederivate zur behandlung von atemwegserkrankungen
EP2415476A4 (de) Zusammensetzung zur vorbeugung und/oder behandlung von hautkrankheiten
ATE510536T1 (de) Verwendung von 2,5-dihydroxybenzol-derivaten zur behandlung von reaktiven gewebeerkrankungen
DE602005021970D1 (de) Verwendung von peptidverbindungen zur behandlung von schmerzen durch knochenkrebs, chemotherapie- und nucleosid-bedingten schmerzen
ATE438623T1 (de) Aroyl-o-piperidinderivate zur behandlung von problemen im zusammenhang mit diabetes
ATE446754T1 (de) Verbindungen zur behandlung von schizophrenie und/oder glucoregulatorische auffälligkeiten
EP1905452A4 (de) Wirkstoff zur prävention oder behandlung von glaukomen
EP1924269A4 (de) Vegetationswasser-zusammensetzung zur behandlung von entzündlichen hautkrankheiten
DE502006007982D1 (de) Neue arzneimittelkombinationen zur behandlung von atemwegserkrankungen
EP2716285A3 (de) Neues Verfahren zur Identifikation von Komponenten zur Behandlung und/oder Verhinderung von mit Erkrankungen zusammenhängendem Knochenschwund
DE602006017367D1 (de) Amino-oxo-indolyliden-verbindungen zur verwendung in der behandlung von juckender kopfhaut